Literature DB >> 22797560

The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.

Ruduwaan Salie1, Johannes A Moolman, Amanda Lochner.   

Abstract

The aim of this study was to investigate the mechanism of beta-adrenergic preconditioning (BPC). The roles of adenosine and its receptor subtypes, the generation of oxygen free radicals (ROS) and activation of the K(ATP) channels as well as the phosphoinositide-3-kinase (PI(3)K)/PKB/Akt and extracellular signal-regulated kinase (ERK) signal transduction pathways during the triggering and mediation phases were evaluated. Using the isolated working rat heart, BPC was elicited by administration of denopamine (beta1 adrenergic receptor agonist, 10(-7) M), isoproterenol (beta1/beta2 adrenergic receptor agonist, 10(-7) M) or formoterol (beta2 adrenergic receptor agonist, 10(-9) M) for 5 min followed by 5 min washout. Index ischaemia was 35 min regional ischaemia and infarct size determined using the tetrazolium method. The role of adenosine was studied using adenosine deaminase and selective antagonists as well as the PI(3)K and ERK inhibitors, wortmannin and PD98,059, bracketing the triggering and mediating phases. Involvement of ROS, PKC, the mitochondrial K(ATP) channels, release of endogenous opioids and bradykinin was studied by administration of N-acetyl cysteine (NAC), bisindolylmaleimide, the K(ATP) channel blocker 5-hydroxydecanoate (5-HD), naloxone or HOE140, respectively. Activation of PKB/Akt and ERKp44/p42 during triggering and reperfusion was determined by Western blot. Preconditioning with all three beta-adrenergic receptor agonists caused a reduction in infarct size and an improvement in postischaemic function. BPC preconditioning with isoproterenol, denopamine or formoterol was abolished by the adenosine A3 receptor antagonist MRS1191 during both the triggering and mediation phases. Isoproterenol-induced preconditioning (beta1/beta2 PC) was attenuated by MRS1754, an adenosine A(2B) receptor antagonist, during the triggering phase and abolished during reperfusion. The mediation phase of beta1/beta2 PC was also abolished by ZM241385, an adenosine A(2A) antagonist. The free radical scavenger NAC caused a significant attenuation of cardioprotection induced by isoproterenol when administered during both trigger and mediation phases, while being effective during the trigger phase with denopamine and during reperfusion in formoterol preconditioned hearts. The mitochondrial K(ATP) channel blocker, 5-HD, was without effect on beta1/beta2 PC during both triggering and mediation phases. BPC in rat hearts is dependent on activation of the A(3) adenosine receptors by endogenously produced adenosine and production of free radicals during the triggering and mediation phases while the A(2A) and A(2B) adenosine receptors participate mainly during reperfusion. The mitochondrial K(ATP) channels do not contribute to cardioprotection at any stage. Activation of ERK and PI3K/PKB/Akt during the triggering and reperfusion phases is associated with cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797560     DOI: 10.1007/s00395-012-0281-5

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  9 in total

1.  β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.

Authors:  Laurel A Grisanti; Jennifer A Talarico; Rhonda L Carter; Justine E Yu; Ashley A Repas; Scott W Radcliffe; Hoang-Ai Tang; Catherine A Makarewich; Steven R Houser; Douglas G Tilley
Journal:  J Mol Cell Cardiol       Date:  2014-02-22       Impact factor: 5.000

Review 2.  Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences.

Authors:  Alberto Aimo; Chiara Borrelli; Alberto Giannoni; Luigi Emilio Pastormerlo; Andrea Barison; Gianluca Mirizzi; Michele Emdin; Claudio Passino
Journal:  World J Cardiol       Date:  2015-10-26

Review 3.  Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential.

Authors:  Robert T Mallet; Eugenia B Manukhina; Steven Shea Ruelas; James L Caffrey; H Fred Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

4.  pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury.

Authors:  T Pasqua; B Tota; C Penna; A Corti; M C Cerra; P Loh Y; T Angelone
Journal:  J Endocrinol       Date:  2015-09-23       Impact factor: 4.286

5.  Cardioprotection via the skin: nociceptor-induced conditioning against cardiac MI in the NIC of time.

Authors:  Xiaoping Ren; Anne E Roessler; Thomas L Lynch; Lauren Haar; Faryal Mallick; Yong Lui; Michael Tranter; Michelle Huan Ren; Wen Rui Xie; Guo-Chang Fan; Jun-Ming Zhang; Evangelia G Kranias; Ahmad Anjak; Sheryl Koch; Min Jiang; Qing Miao; Yang Wang; Albert Cohen; Jack Rubinstein; Neal L Weintraub; W Keith Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-21       Impact factor: 5.125

Review 6.  Positive oxidative stress in aging and aging-related disease tolerance.

Authors:  Liang-Jun Yan
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

7.  Increased fatty acid metabolism attenuates cardiac resistance to β-adrenoceptor activation via mitochondrial reactive oxygen species: A potential mechanism of hypoglycemia-induced myocardial injury in diabetes.

Authors:  Lishan Huang; Zhou Chen; Ruiyu Chen; Lu Lin; Lingjia Ren; Meilian Zhang; Libin Liu
Journal:  Redox Biol       Date:  2022-04-21       Impact factor: 10.787

8.  High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury.

Authors:  Ruduwaan Salie; Barbara Huisamen; Amanda Lochner
Journal:  Cardiovasc Diabetol       Date:  2014-07-18       Impact factor: 9.951

9.  Ticagrelor Prevents Endothelial Cell Apoptosis through the Adenosine Signalling Pathway in the Early Stages of Hypoxia.

Authors:  Catherine Feliu; Hélène Peyret; Sylvie Brassart-Pasco; Floriane Oszust; Gaël Poitevin; Philippe Nguyen; Hervé Millart; Zoubir Djerada
Journal:  Biomolecules       Date:  2020-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.